Bright Minds Biosciences Inc. (DRUG) Dividend History

Bright Minds Biosciences Inc. (DRUG) is a biotechnology company focused on developing psychedelic-inspired medicines for mental health and neurological disorders. The company leverages innovative compounds and research to create therapies aimed at providing novel treatment options for conditions such as depression, anxiety, and trauma-related disorders.

Dividend History

Bright Minds Biosciences Inc. currently does not pay dividends

Company News

  • Firefly Neuroscience, a Nasdaq-listed AI company, announced its Q3 2024 financial results and provided updates on its partnerships with pharmaceutical companies like Bright Minds Bioscience, Novartis, and Takeda to advance its Brain Network Analytics (BNA) technology for neurological and mental disorder treatments.

    GlobeNewswire Inc.
    Featured Companies: AIFF
  • Bright Minds Biosciences Inc. has closed a $35 million private placement, with participation from several healthcare investors. The company plans to use the proceeds for research and development related to its drug development programs.

    GlobeNewswire Inc.
  • Bright Minds Biosciences announced the initiation of a Phase 2 clinical trial of BMB-101, a novel 5-HT2C agonist, for the treatment of drug-resistant epilepsies. The company will host a KOL event to discuss the trial and the unmet needs in epilepsy care.

    GlobeNewswire Inc.
  • Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. Decibel Therapeutics, Inc. (NASDAQ: DBTX) gained 76% to $4.9150 after Regeneron announced it will acquire the company. Benitec Biopharma Inc. (NASDAQ: BNTC) jumped 75.8% to $3.3937. Benitec Biopharma reported pricing of $30 million underwritten public offering. Renovaro Biosciences Inc. (NASDAQ: RENB) shares gained 68.2% to $1.43 after the company and AI-focused GEDi Cube announced a binding, exclusive letter of intent to merge. T Stamp Inc. (NASDAQ: IDAI) climbed 48.8% to $2.3518. EBET, Inc. (NASDAQ: EBET) surged 40.5% to $0.0405 on abnormally-high volume. The stock was set to be suspended at the opening of business today unless the company requested an appeal of Nasdaq's Listing Qualifications Department's determination. Millennium Group International Holdings Limited (NASDAQ: MGIH) gained 40% to $2.7003 on strong volume. Science 37 Holdings, Inc. (NASDAQ: SNCE) jumped 39.3% to $0.3765 following better-than-expected quarterly results. BioNexus Gene Lab Corp. (NASDAQ: BGLC) gained 36.5% to $1.5699. Kubient, Inc. (NASDAQ: KBNT) rose 33.7% to $0.63. Oportun Financial Corporation (NASDAQ: OPRT) gained 31.3% to $6.90 following strong quarterly results. Poseida Therapeutics, Inc. (NASDAQ: PSTX) climbed 31.3% to $2.60 following quarterly results. Mirati Therapeutics, Inc. (NASDAQ: MRTX) surged 30.1% to $36.17 after the company reported second-quarter financial results. Also, B. Riley Securities upgraded the stock from Neutral to Buy and announced a $45 price target. Allbirds, Inc. (NASDAQ: BIRD) gained 29% to $1.65 after the company reported better-than-expected second-quarter financial results. Array Technologies, Inc. (NASDAQ: ARRY) climbed 27.8% to $22.85 following a second-quarter earnings beat. Computer Task Group, Incorporated (NASDAQ: CTG) gained 27.8% to $10.23 after the company announced it will be acquired by Cegeka for $10.50 per share. LivePerson, Inc. (NASDAQ: LPSN) rose 27.5% to $5.09 r after the company announced a second-quarter earnings beat. The company named John Collins as the Interim CEO. PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) gained 22.3% to $8.31 after the company reported better-than-expected second-quarter EPS results. Celsius Holdings, Inc. (NASDAQ: CELH) jumped 21.8% to $174.73 after the company reported better-than-expected second-quarter financial results. United Insurance Holdings Corp. (NASDAQ: UIHC) gained 21.3% to $6.83. DMC Global Inc. (NASDAQ: BOOM) climbed 19.8% to $21.03 following quarterly results. Dutch Bros Inc. (NYSE: BROS) surged 19.8% to $33.55 after the company reported better-than-expected quarterly EPS results and issued FY23 guidance. Azenta, Inc. (NASDAQ: AZTA) gained 19.6% to $57.45 fter the company reported better-than-expected third-quarter financial results and issued fourth-quarter EPS guidance above estimates. Additionally, Needham raised its price target from $55 to $65 on the stock. ThredUp Inc. (NASDAQ: TDUP) climbed 19.5% to $3.85 after the company reported better-than-expected second-quarter financial results and issued revenue guidance. Also, Goldman Sachs raised its price target from $3 to $4 on the stock. Planet Green Holdings Corp. (NASDAQ: PLAG) rose 17.5% to $0.5670. Anavex Life Sciences Corp. (NASDAQ: AVXL) climbed 16.2% to $ 9.33. Rapid7, ...

    Benzinga
  • U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Tuesday. The Dow traded down 0.64% to 35,246.87 while the NASDAQ fell 0.98% to 13,857.43. The S&P 500, also fell, dropping, 0.65% to 4,489.12. Check This Out: Top 5 Tech Stocks Which Could Rescue Your Portfolio This Month   Leading and Lagging Sectors Health care shares jumped by 0.3% on Tuesday. In trading on Tuesday, financial shares fell 1.3%.   Top Headline United Parcel Service Inc (NYSE: UPS) reported mixed second-quarter financial results and issued FY23 revenue guidance below estimates. United Parcel Service reported a second-quarter FY23 revenue decline of 10.9% year-over-year to $22.055 billion, missing the consensus of $23.11 billion. Adjusted EPS was $2.54, compared to $3.29, beating the consensus of $2.50. For FY23, UPS now expects consolidated revenue to be about $93 billion (prior $97 billion) Vs. consensus of $96.77 billion and an adjusted operating margin of around 11.8% (prior 12.8%).   Equities Trading UP Nuburu, Inc. (NYSE: BURU) shares shot up 38% to $14.31 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser technology. Shares of Paymentus Holdings, Inc. (NYSE: PAY) got a boost, shooting 34% to $14.31 after the company reported better-than-expected second-quarter financial results. Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares were also up, gaining 36% to $4.37 after the company disclosed data for BMB-101.   Equities Trading ...

    Benzinga
    Featured Companies: BURU DTSS PAY UPS
Dividend data last updated 06/07/2025 06:32:16 UTC